Literature DB >> 33504582

Flavoured tobacco product restrictions in Massachusetts associated with reductions in adolescent cigarette and e-cigarette use.

Summer Sherburne Hawkins1, Claudia Kruzik2, Michael O'Brien2, Rebekah Levine Coley2.   

Abstract

BACKGROUND: In the USA, many states do not pre-empt municipalities from enacting stricter tobacco-control policies than state or federal laws. Several municipalities in Massachusetts have passed progressive local laws aimed at reducing adolescent tobacco use. We exploited this variability to examine the associations between county-level flavoured tobacco product restrictions, tobacco 21 policies and smoke-free laws prohibiting e-cigarettes with adolescent cigarette and e-cigarette use in Massachusetts, and to assess whether policy effects varied by age.
METHODS: We conducted difference-in-differences models to link changes in county-level tobacco-control policies to changes in adolescents' use of cigarettes and e-cigarettes using 2011-2017 biennial Massachusetts Youth Health Surveys.
RESULTS: Counties with greater implementation of flavoured tobacco product restrictions were associated with a decrease in the level of cigarette use among users (Coefficient -1.56; 95% CI -2.54 to -0.58). A significant interaction (p=0.03) revealed the largest reductions among 14 and 18 year olds. Increasing flavoured tobacco product restrictions were also associated with reductions in the likelihood of e-cigarette use (Coefficient -0.87; 95% CI -1.68 to -0.06). Increasing tobacco 21 restrictions were associated with decreases in cigarette use only among 18 year olds, while there was no evidence of associations between smoke-free laws with use of either tobacco product.
CONCLUSIONS: Adolescents in Massachusetts decreased their use of cigarettes and e-cigarettes in response to local restrictions that limited the sale of flavoured tobacco products to adult-only retail tobacco stores. Local legislation can reduce adolescent tobacco use and municipalities should enact stricter tobacco-control policies when not pre-empted by state law. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  non-cigarette tobacco products; prevention; public policy

Mesh:

Substances:

Year:  2021        PMID: 33504582     DOI: 10.1136/tobaccocontrol-2020-056159

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   6.953


  5 in total

1.  Youth tobacco use before and after flavoured tobacco sales restrictions in Oakland, California and San Francisco, California.

Authors:  Jessica Liu; Lester Hartman; Andy S L Tan; Jonathan P Winickoff
Journal:  Tob Control       Date:  2022-03-17       Impact factor: 6.953

2.  Young people's e-cigarette risk perceptions, policy attitudes, and past-month nicotine vaping in 30 U.S. cities.

Authors:  Erin A Vogel; Lisa Henriksen; Nina C Schleicher; Judith J Prochaska
Journal:  Drug Alcohol Depend       Date:  2021-10-09       Impact factor: 4.492

3.  Sources of flavoured e-cigarettes among California youth and young adults: associations with local flavoured tobacco sales restrictions.

Authors:  Shivani Mathur Gaiha; Lisa Henriksen; Bonnie Halpern-Felsher; Todd Rogers; Ashley L Feld; Jennifer Gaber; Elizabeth Andersen-Rodgers
Journal:  Tob Control       Date:  2021-04-13       Impact factor: 6.953

4.  Youth Tobacco Use Before and After Local Sales Restrictions on Flavored and Menthol Tobacco Products in Minnesota.

Authors:  Lindsay T Olson; Ellen M Coats; Todd Rogers; Elizabeth M Brown; James Nonnemaker; Ashley M Ross; Janine Delahanty; Xin Xu
Journal:  J Adolesc Health       Date:  2022-03-07       Impact factor: 7.830

Review 5.  A Comprehensive Qualitative Review of Studies Evaluating the Impact of Local US Laws Restricting the Sale of Flavored and Menthol Tobacco Products.

Authors:  Todd Rogers; Elizabeth M Brown; Leah Siegel-Reamer; Basmah Rahman; Ashley L Feld; Minal Patel; Donna Vallone; Barbara A Schillo
Journal:  Nicotine Tob Res       Date:  2022-03-01       Impact factor: 4.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.